Chief Executive Officer · Tenaya Therapeutics, Inc. (TNYA)

Faraz Ali

A named executive officer of Tenaya Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,881,396

Salary $664,173Stock awards $141,924

FY2024: $3,281,901

1st of 2 named executive officers at Tenaya Therapeutics by FY2025 total.

2 named officers on file for Tenaya Therapeutics, FY2025

Faraz Ali’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tenaya Therapeutics’s whole pay program stands against its peers

  • Tenaya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TNYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Faraz Ali’s full pay file as a PDF — free

More than this page: up to 10 years of Faraz’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Faraz Ali compensation by year

Tenaya Therapeutics Summary Compensation Table · all 6 fiscal years held
In US dollars, as Tenaya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024FY2025
Salary$425,000$493,750$571,459$593,800$636,189$664,173
Bonus$126,500$0$0$0$0$0
Stock awards$0$0$0$382,500$443,700$141,924
Option awards$197,500$4,259,989$4,751,013$1,617,503$2,047,927$755,507
Non-equity incentive$0$216,120$242,700$293,931$153,450$319,275
Pension and deferred compensation$0$0$0$0$0$0
All other$1,300$896$2,228$2,328$636$516
Total$750,300$4,970,756$5,567,400$2,890,062$3,281,901$1,881,396

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tenaya Therapeutics, Inc. DEF 14A filed April 16, 2026, accession 0001193125-26-158079, and prior-year filings.

How this page was built: the Tenaya Therapeutics, Inc. filed document, accession 0001193125-26-158079. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2026.

$750K
$5.0M
$5.6M
$2.9M
$3.3M
$1.9M
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU94,063$66,973—
RSU53,125$37,825—
RSU46,875$33,375—
RSU17,212$12,255—
Option16,725—$1.21
Option196,875—$3.06
Option273,542—$5.22
Option514,584—$1.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Tenaya Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

8 Form 4 lines since the FY2025 proxy (filed April 16, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-17Sale—3,499$0.32536,283
2026-09-10Grant or award derivative—732,500$0.00732,500
2026-09-10Grant or award—122,000$0.00539,782
2026-08-17Sale—3,969$0.71430,208
2026-08-17Sale—5,020$0.71425,188
2026-08-17Sale—7,406$0.71417,782
2026-08-17Sale—5,837$0.71434,177
2026-05-18Sale—3,390$0.79440,014

The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Tenaya Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Faraz Ali · this pageChief Executive Officer$1,881,396
Whittemore TingleyChief Medical Officer$1,174,644

The full Tenaya Therapeutics compensation record

free company brief

This page is one person within Tenaya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tenaya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Faraz Ali's compensation dossier · One-time report. No refunds.